F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma
Conditions: Non-Hodgkin ' s Lymphoma Interventions: Drug: After preconditioning with chemotherapy, F01 will be evaluated. Sponsors: Shanghai Simnova Biotechnology Co.,Ltd.; Wuhan Union Hospital, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer
DiscussionCompARE is designed to be efficient and cost-effective in response to new data, emerging new treatments or difficulties, with the aim of bringing new treatment options for these patients.Trial registrationISRCTNISRCTN41478539. Registered on 29 April 2015 (Source: Trials)
Source: Trials - January 15, 2024 Category: Research Source Type: clinical trials
Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy
Conditions: Gastric Cancer; Tumor Microenvironment; Immunotherapy; Chemotherapy Interventions: Drug: SOX plus PD-1 inhibitor; Procedure: Gastroscopic biopsy Sponsors: Chinese PLA General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer
Conditions: DNA Damage; Gastric Cancer Interventions: Diagnostic Test: investigated biomarkers regarding the efficacy of first-line chemotherapy Sponsors: Regina Elena Cancer Institute; Azienda Sanitaria Locale n. 2 - Lanciano Vasto Chieti; Campus Bio-Medico University; Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Azienda Ospedaliera " Sant ' Andrea " ; University of Roma La Sapienza; Azienda Ospedaliero Universitaria Policlinico Modena Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Explored About Temperature Packing Care to Improve the Quality of Life for Chemotherapy Induced Peripheral Neuropathy (CIPN) in Colorectal Cancer and Gastric Cancer Patient
Conditions: Colorectal Cancer; Gastric Cancer; Chemotherapy-induced Peripheral Neuropathy Interventions: Other: Hot compressing; Other: Cold compressing Sponsors: National Taiwan University Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial
Conditions: Hepatocellular Carcinoma Interventions: Procedure: Hepatic arterial infusion chemotherapy; Drug: Lenvatinib; Drug: Toripalimab; Drug: oxaliplatin , fluorouracil, and leucovorin Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial
Conditions: Colorectal Cancer; Metastatic Colon Cancer; Metastatic Colorectal Cancer Interventions: Behavioral: Exercise Program Sponsors: Dana-Farber Cancer Institute; American Cancer Society, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
A Study of TQB2930 for Injection Monotherapy or Combination Chemotherapy in Patients With Recurrent/Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer; Recurrent Breast Cancer Interventions: Drug: TQB2930 for injection; Drug: Docetaxel injection Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Romiplostim in Chemotherapy-Induced Thrombocytopenia
Conditions: Chemotherapy-induced Thrombocytopenia; Solid Malignancy Interventions: Drug: Romiplostim Sponsors: Ain Shams University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore
Conditions: Gastric Cancer Interventions: Drug: Cadonilimab plus CapeOX chemotherapy Sponsors: Nanfang Hospital, Southern Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Perioperative Adebrelimab and Chemotherapy in Esophageal and Esophagogastric Junction Carcinoma
Conditions: Adebrelimab; Esophageal Cancer; Perioperative Period Interventions: Drug: adebrelimab,Paclitaxel,Lobaplatin,Fluorouracil Sponsors: Xijing Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC)
Conditions: Non-Small-Cell Lung Cancer Interventions: Drug: Golidocitinib; Drug: Sintilimab; Drug: platinum doublet chemotherapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Dizal Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer
Conditions: Electroacupuncture; Olanzapine-contained Four-drug Antiemetic; Nausea and Vomiting Interventions: Device: Electroacupuncture; Drug: Standard antiemetic treatment; Device: Sham electroacupuncture; Drug: Standard antiemetic treatment Sponsors: Jiuda Zhao Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With Transarterial Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Real-World Study
Conditions: Hepatocellular Carcinoma Interventions: Drug: Atezolizumab combined with Bevacizumab; Drug: Sintilimab combined with Bevacizumab; Procedure: Transcatheter arterial chemoembolization and hepatic arterial infusion chemotherapy Sponsors: Sun Yat-sen University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Investigate the Efficacy of Chemotherapy in Patients With Positive ctDNA After Surgery and Adjuvant Chemotherapy for a Stage III Colorectal Cancer
Conditions: Colon or Upper Rectum Adenocarcinoma Interventions: Drug: " FOLFIRI " cures; Drug: Trifluridine cures; Biological: BIOLOGICAL ASSESSMENT; Other: Questionnaires; Other: Thoracic-abdomino-pelvic scan or MRI Sponsors: Centre Hospitalier Universitaire Dijon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
